2 0 CO 80309, USA.
anamnesis. For the Shanghai cohort, families from the Bio-x SCZ Biobank with at least three 1 0 5 siblings, two of whom were diagnosed with SCZ, were selected. All families from the Bio-x SCZ 1 0 6
Biobank were recruited from the city of Shanghai and the provinces of Hebei, Liaoning and Taiwan and 13 from Shanghai), with SCZ patients, matched unaffected siblings and parents, 1 1 0 were used in this study (Figure 1 ). For detailed demographic characteristics of all individuals in 1 1 1 the 23 families, please refer to Supplementary Table S1 . All subjects gave written informed 1 1 2 consent with the approval of the local research ethics committees. Genomics Resource (RGR). Lymphocytes from the whole blood samples were transformed into whole blood samples were also collected with anticoagulant tubes. DNA was extracted from 1 2 4 blood lymphocytes by standard procedures using FlexiGene DNA kits (Fuji, Tokyo, Japan). DNA libraries were prepared using protocols recommended by Illumina (Illumina, San Diego, 1 2 6 All rights reserved. No reuse allowed without permission. peer-reviewed) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/19011007 doi: medRxiv preprint first posted online Nov. 4, 2019 ; CA). WGS was performed on Illumina HiSeq-X Ten platform with 150 base-pair read length FastQC (v0.11.8) was used to perform quality checks on all samples across Taiwan and Shanghai 1 3 0 cohorts (Supplementary Figure S1) .
The GATK best practices of variant calling were applied to process all raw reads from both GRCh37 build of the human reference genome with BWA-mem 19 . Then the aligned reads in containing indels were realigned with GATK's IndelRealigner tool. Next, GATK was used to 1 3 6 perform Base Quality Score Recalibration (BQSR). Quality control after alignment was 1 3 7 performed using Picard (v2.20.4) CollectAlignmentSummaryMetrics ( Supplementary Table S2 ). systematically remove potentially false positively called variants, we applied the following 1 4 1 quality filters for each variant: (1) the quality score normalized by allele depth is less than 2; (2) 1 4 2 the root mean square of the mapping quality is less than 40; (3) the strand bias is more than 60; 1 4 3 (4) three consecutive variants were clustered within 10 bases; and (5) the FILTER tag is not 
Kinship analysis, DNM calling and annotation 1 4 6
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We used PLINK to perform kinship analysis 20 . Briefly, for a given family, if the father was 1 4 7
shown to be within the third degree relative to the mother, the family would be excluded; if the 1 4 8 child was not shown to be the first degree relative to the parents, the child would be excluded.
4 9
To ensure the DNM calls with high confidence, three tools, GATK PhyseByTransmission (PBT), DNMs called by all three tools consistently were considered as candidate DNMs. PBT was run with the following command: TrioDeNovo was run with the following command: DeNovoGear was run with the following command: After obtaining consistently called DNMs, the following five criteria were applied to retain high 1 6 2 quality calls tagged with PASS in the FILTER annotation: (1) quality score is greater than or heterozygote; (4) phred-scaled maximum likelihood of heterozygote for the parents is less than 1 6 5 50; and (5) phred-scaled maximum likelihood of heterozygote of the child is 0. DNMs with MAF 1 6 6 All rights reserved. No reuse allowed without permission. peer-reviewed) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/19011007 doi: medRxiv preprint first posted online Nov. 4, 2019 ;  greater than 0.01 in East Asian populations were further excluded by querying gnomAD 1 6 7 (https://gnomad.broadinstitute.org/) and EXac (http://exac.broadinstitute.org/). Please refer to the distributions of DNM quality scores. Remaining DNMs were annotated using ANNOVAR 24 . 1 7 0
Polymerase chain reaction (PCR)-based Sanger sequencing validation
For the families where candidate DNMs were found, DNA from all members of the family was 1 7 2 subjected to PCR-based Sanger sequencing by capillary electrophoresis according to standard 1 7 3 molecular biology practices (ABI 3130 genetic analyzer, ThermoFisher Scientific). Primer3Plus was used to design the PCR primers 25 . For the GJC1 mutation, the forward primer sequence was 1 7 5 5'-TTAGGTTTGGGTTGGCTCTG -3' and the reverse primer sequence was 5'-1 7 6 CACGGTGAAGCAGACAAGAA -3'. For the HIST1H2AD insertion, the forward primer 1 7 7 sequence was 5'-CTCGTTTTACTTGCCCTTGG -3' and the reverse primer sequence was 5'- Reactions were performed on an Eppendorf MasterCycler (Eppendorf North America, New York, As the spontaneous background mutation rates vary greatly between genes, those carrying peer-reviewed) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Identification of genes implicated by coding DNMs in SCZ
1 1 mapped to these regions in unaffected siblings, and then assessed the significance of the 2 1 2 comparison using 10,000 within-sibship case-control label-swapping permutations. P value was 2 1 3 calculated as the proportion of permutations with relative risk (RR) as or more extreme than in 2 1 4 the observed data. Multiple lines of evidence have shown that prenatal maternal infection, malnutrition and stress 2 1 7 are risk factors for SCZ [31] [32] [33] . The neurodevelopmental model of SCZ posits that a perturbation in 2 1 8 early brain development leads to an altered brain developmental trajectory that is sensitive to converging on the emergence of SCZ in early adulthood 34 . It was hypothesized that DNMs 2 2 1 drove dysfunction of genes in early brain development and that this dysfunction confers risks for 2 2 2 subsequent SCZ. To determine whether DNM-implicated genes (loss-of-function DNM genes 2 2 3 and DNM-burdened genes) were involved in early brain development, human brain and BrainSpan expression data was evaluated by leveraging the developmental effect scores 2 3 0 curated in a previous publication 37 . A developmental effect score measures the effect of age on 2 3 1 expression per gene per brain structure, with a higher developmental effect score of a gene in a 2 3 2 given brain structure indicating a stronger involvement of brain development in that structure. By 2 3 3 10,000 gene label-swapping permutation, P value of a DNM gene for a given brain structure was 2 3 4 All rights reserved. No reuse allowed without permission. peer-reviewed) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/19011007 doi: medRxiv preprint first posted online Nov. 4, 2019 ; calculated as the proportion of permutations with developmental effect scores as or more 2 3 5 extreme than the observed value. DNM genes were then further evaluated in brain developmental 2 3 6 expression data from other species (macaque and mouse) 38, 39 . To determine whether DNM-implicated genes are among the loci found by the genome-wide association study (GWAS) of SCZ or SCZ-related traits, we used GWAS summary statistics was that the GWAS SNP is located within 10 kb of the gene boundaries. 
Co-expression and enrichment analysis 2 4 5
To explore the potential functions or pathological pathways affected by DNM-implicated genes, genes co-expressed with the candidate DNM gene were input as the target gene set and all genes 2 5 0 in the BrainCloud expression data were input as the reference gene set. Enrichments with B-H 2 5 1 FDR-corrected P values less than 0.05 were considered significantly enriched. To examine cell-type specific expression of DNM-implicated genes, brain tissue single nucleus RNA-seq (snRNA-seq) data of middle temporal gyrus (MTG), of which the cells have been sub-2 5 5 typed from Allen Brain Atlas (https://celltypes.brain-map.org/rnaseq) and single cell expression Seurat 49 . For a given DNM gene, the dominant cell type(s) with high expression were The goal of our study was to identify DNM disturbed genes, of which the dysfunctions can 2 6 4 contribute to the pathogenesis of SCZ. We identified coding DNM-implicated genes and genes 2 6 5 carrying more DNM burdens in SCZ patients than their unaffected siblings. These DNM-2 6 6 implicated genes were potentially detrimental and subsequent analyses were performed to 2 6 7 explore their pathological effects ( Figure 1 ). To ensure parental unrelatedness and that the children are indeed biological offspring of their 2 7 0 parents, kinship analysis was performed for each individual family. For the Taiwan cohort, one 2 7 1 family (Family ID: 35-04560) was excluded as the father is within the third degree relative of the 2 7 2 mother, one family (Family ID: 35-93405) was excluded as the father was not found to be related 2 7 3 to any of the children and one child in one family was excluded as he was found to be unrelated 2 7 4 to his parents (Individual ID: 35-02497-01) ( Supplementary Table S1 ). Three children from Shanghai cohort were excluded as they were unrelated to their respective parents (Individual IDs: CHG000225, CHG000236 and CHG000246) ( Supplementary Table S1 ). A total of 21 families to unrelatedness, please refer to Supplementary Table S1 .
Cell-type specific expression analysis
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Identification of DNMs and genes implicated by DNMs
In this study, 70.71 ± 6.83 de novo point mutations and 6.31 ± 3.64 de novo indel mutations with 2 8 1 high confidence per individual were identified. The observed de novo point mutation rate of 2 8 2 1.145 × 10 -8 was consistent with the neutral expectation of 1.140 × 10 -8 (P = 0.95, two-sided 2 8 3 exact binomial test) 23 . The observed de novo indel mutation rate of 1.022 × 10 -9 was consistent 2 8 4 with the neutral expectation of 1.420 × 10 -9 (P = 0.500, two-sided exact binomial test) 23 . All Figure S4 ). No obvious difference was observed between unaffected siblings and SCZ patients with regards differences were observed between unaffected siblings and SCZ patients with regards to the 2 9 0 percentages of DNMs occurring in exons (unaffected siblings: 29.85% versus SCZ patients: 2 9 1 30.29%) and introns (unaffected siblings: 1.53% versus SCZ patients: 2.03%). The 2 9 2 nonsynonymous-to-synonymous ratio in SCZ patients was not found to be different from the 2 9 3 ratio in unaffected siblings 50 , which might be attributed to the limited sample size. Two 2 9 4 nonsense loss-of-function DNMs implicating GJC1 and HIST1H2AD respectively were 2 9 5 identified in SCZ patients (Table 1 and Supplementary Table S4 ). The two loss-of-function 2 9 6 DNMs were visually verified by IGV ( Supplementary Figure S5 and S6) and then were were higher than expected by chance, we compared the nonsense mutation probabilities of GJC1 3 0 0 and HIST1H2AD to those of all genes calculated in Samocha et al. 51 . Nonsense DNMs were not 3 0 1 All rights reserved. No reuse allowed without permission. peer-reviewed) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
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shown in Supplementary Table S4 . To identify genes implicated by these protein-coding DNMs, correction was used to reduce the false discovery rate. Only GJC1 and HIST1H2AD carrying 3 1 0 nonsense DNMs were significantly identified to be implicated by DNMs (Supplementary Table   3 1 1 S5). We applied another background mutation rate-based model, referred to as the chimpanzee-3 1 2 human divergence model, which also showed GJC1 and HIST1H2AD were significantly Supplementary Table S4 ; mutations with CADD phred-like scores greater than or equal to 30 is 3 1 7 the most severe 0.1% of mutations) 53 . Moreover, GJC1 falls into the haploinsufficient category To investigate whether GJC1 and HIST1H2AD were also implicated by rare variants as DNMs in controls. Rare variants in the exons of GJC1 were significantly associated to SCZ (Table 2) . 
Identification of genes burdened with DNMs in SCZ patients
Previous studies have shown that 99% of the DNMs occurred in non-coding regions 10 . DNMs Based on this assumption, for a given gene, we compared the number of DNMs that occurred in implicated enhancers for DPYSL2, NBPF1, SNX9 and MSI2 ( Supplementary Table S6 ), 3 3 7 suggesting the dysregulation of these genes may predispose an individual to SCZ. One single Supplementary Table S6 . Interestingly, no DNM occurred in promoters of the ten genes. peer-reviewed) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
In the following analyses, coding DNM-implicated genes (GJC1 and HIST1H2AD, 3 4 6 Supplementary Table S5 ) and DNM-burdened genes (Table 3) were as assumed to be 3 4 7 detrimental DNM genes to explore their potential functions that might be related to SCZ. Supplementary Table S5 ) and genes carrying more DNMs in SCZ patients (Table 3) ,
were involved in brain development, we leveraged the developmental expression data of potentially detrimental DNM genes with higher expression in prefrontal cortices was more than expected by chance ( Supplementary Figure S10 , P = 0.05, hypergeometric test). We next sought 3 6 0 to examine whether the involvements of detrimental DNM genes in PFC development were 3 6 1 preserved in other brain regions. The genes with available developmental data in BrainSpan were 3 6 2 analyzed. It was found that GJC1, SDK1 and GCNT2 were still involved in the developments of 3 6 3 other brain regions (Supplementary Figure S11) . To examine whether the involvements of 3 6 4 detrimental DNM genes in human brain development were conserved across species, we first HIST1H2AD, DPYSL2, SDK1 and MSI2 showed higher expression in prenatal stage than the 3 6 8 All rights reserved. No reuse allowed without permission. peer-reviewed) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/19011007 doi: medRxiv preprint first posted online Nov. 4, 2019 ; expression in postnatal stage (Supplementary Figure S12) . We then queried the brain decreased with time ( Supplementary Figure 13) , which implied their involvements in prenatal high expression in embryonic stage followed by a massive postnatal decrease in the rat midbrain- To determine whether the detrimental DNM genes are involved more broadly in SCZ, we asked whether common variants present in the DNM genes confer risk for SCZ and SCZ-associated traits. We extracted all SNPs that occur within 10 kb of the DNM genes. For a given trait, the 3 8 0 SNP with the minimum P value mapped to the gene was used to represent the gene risk on the 3 8 1 trait. Genes with minimum SNP P values less than the suggestive threshold of 1 × 10 -5 were 3 8 2 considered as risk genes for the trait. We found that the DNM genes influence risk for SCZ- and drinking primarily ( Supplementary Table 7 ). Of note, GJC1, HIST1H2AD and SDK1 confer Next, we focused on the loss-of-function DNM gene GJC1, a member of the connexin gene 3 8 9 family, which showed strong evidence of SCZ susceptibility ( Supplementary Table S8 ). DNMs 3 9 0 All rights reserved. No reuse allowed without permission. peer-reviewed) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
Common variants in detrimental DNM genes may influence risks of SCZ-associated traits
GJC1 co-expressed with multiple potassium channel genes and is a potentially target for SCZ
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/19011007 doi: medRxiv preprint first posted online Nov. 4, 2019 ;  in other brain-associated connexin genes were also found in psychiatric patients (Supplementary 3 9 1 Table S9 ). GJC1 showed higher expression in prenatal stage than the expression in postnatal 3 9 2 stage in PFC and multiple other brain regions, and its involvement in early brain development 3 9 3 was conserved across species (Figures 3; Supplementary Figures S11, S12 and S13). Moreover, 3 9 4 common variants present in GJC1 confer risks for intelligence, educational attainment, cognitive 3 9 5 performance and alcohol abuse, which were associated with SCZ ( Supplementary Table S7 ) 57-60 . To explore the pathogenic effects of GJC1, we first sought to identify the genes that might be impacted by the dysfunction of GJC1. We performed co-expression analysis with Pearson 3 9 8 correlation coefficient greater than 0.8 or less than -0.8 in PFC to identify these genes (Figure 4A and supplementary Table S10 ). Then we leveraged the genes co-expressed with GJC1 to perform 4 0 0 enrichment analysis to identify functions or pathways involved by GJC1. Interestingly, the genes 4 0 1 co-expressed with GJC1 were enriched in SCZ, SCZ drug zuclopenthixol and SCZ-associated 4 0 2 functions or pathways, including potassium ion transport ( Figure 4B and Supplementary Table   4 0 3 S11). Of note, multiple potassium ion channel genes were negatively co-expressed with GJC1 4 0 4 ( Figure 4A ), suggesting their dysfunctions may be subsequent to the dysfunction of GJC1. To determine whether the expression of GJC1 was specific to a certain cell type, we performed 4 0 6 cell type specific analysis of GJC1 expression. GJC1 was predominantly expressed in 4 0 7 glutamatergic excitatory neurons ( Figure 4C and 4D, refer to Supplementary Tables S12 and S13 should be interesting as glutamatergic dysfunction has long been implicated in SCZ 61 . peer-reviewed) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
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In this study, we used two matched SCZ-sibling family cohorts of Han Chinese origin to 4 1 3 investigate DNMs and DNM-implicated genes in SCZ. By integrating this information with 4 1 4 publicly available data, including brain developmental expression profiles and summary GWAS 4 1 5 statistics, we identified DNM-implicated genes that were involved in fetal neurodevelopment. These genes may confer risks for SCZ or SCZ-associated traits, and are potential drug therapy 4 1 7 targets for SCZ. the two connexin genes expressed predominantly in neurons 62 . Our analyses showed that GJC1 4 2 0 was expressed highly in prenatal stage as compared to that in postnatal stage and was expressed 4 2 1 predominantly in glutamatergic excitatory neurons in the human brain ( Figure 4C and 4D ). For 4 2 2 the nonsense mutation identified in our study, its occurrence might trigger the activation of to be formed 63 . The reduction of GJC1 may perturb the co-expressed genes and thus influence peer-reviewed) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/19011007 doi: medRxiv preprint first posted online Nov. 4, 2019 ; 1 indicated its involvement in development is phylogenetically conserved. The dysfunction or loss-4 3 6 of-function can cause lethal effects, thereby such mutation would be eliminated by natural 4 3 7 selection in evolution. Interestingly, all potassium ion channel genes were negatively co-4 3 8 expressed with GJC1. Therefore, the reduction of GJC1 indicates an increase or overactivity of severe cognitive impairments in SCZ 69 . Our findings support these hypotheses. Overall, the loss-
of-function of Cx45 may be a driver of pathogenesis for some SCZ cases. suggested to treat SCZ 72 , which implies the fundamental role of histone in the pathology of SCZ.
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Gene level DNM burden test identified a list of genes carrying more DNMs in SCZ patients than MSI2 were also associated with SCZ ( Supplementary Table 7 ). Another DNM-burdened genes, Except for HIST1H2AD, common variants in these identified DNM genes were not strongly 4 7 8 associated to psychiatric diseases. However, a few of them, GJC1, HIST1H2AD and SDK1, were 4 7 9 strongly associated to SCZ-associated traits, including intelligence, educational attainment, 4 8 0 All rights reserved. No reuse allowed without permission. peer-reviewed) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/19011007 doi: medRxiv preprint first posted online Nov. 4, 2019 ; 3 smoking and drinking. It suggested the significance of these DNM genes in neurodevelopment 4 8 1 and that the lethal mutations occurred in these genes were eliminated by marked reduction of 4 8 2 fecundity in psychiatric patients. with more and independent Chinese family samples are necessary. In summary, we identified a list of DNM-implicated genes which are involved in prenatal 4 9 4 neurodevelopment. Common variants in these DNM-implicated genes had been previously 4 9 5
reported to be associated with SCZ and related traits in previous GWASs, which is consistent 4 9 6 with our analyses. DNMs implicating the enhancers may contribute to pathogenesis of SCZ by 4 9 7 dysregulating the expression of genes. GJC1 is one of these DNM-implicated genes that is 4 9 8 primarily expressed in glutamatergic neurons and may be involved in the modulation of ion 4 9 9 channel functions, which has also been implicated in SCZ in previous studies 78, 79 . Overall, our participating sites for their contributions to this study. peer-reviewed) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
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